Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy

Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy

US Patent 11891614 · Granted Feb 6, 2024

Estimated economic value: $2,843,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymer nanoparticle compositions for in vivo expression of polypeptides2025
Targeted gene insertion for improved immune cells therapy2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2025
Method for improving production of car T cells2025
Methods of exogenous drug activation of chemical-induced signaling complexes exp2025
Optimized mRNA encoding CAS9 for use in LNPs2025
Method for generating t-cells compatible for allogenic transplantation2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Viral vectors and packaging cell lines2025
Targeted gene integration of NK inhibitors genes for improved immune cells thera2025
Method for generating immune cells resistant to arginine and/or tryptophan deple2024